Command Palette

Search for a command to run...

Clinical Trials · NCT02483767

Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Peking Union Medical College Hospital
Enrollment
98
Start date
Jun 2015
Locations
See registry
Primary endpoint
ovarian failure
View Gonadorelin compound reference